Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis

Respiratory Research
Ahmed EdrisLies Lahousse

Abstract

Since novel treatments to target eosinophilic inflammation in Type 2 asthma are emerging, we aimed to evaluate and meta-analyze the efficacy of monoclonal antibodies to reduce exacerbation rate. PubMed and Web of Science were searched for phase II and phase III randomized clinical trials with monoclonal antibodies targeting key mediators of type 2-associated asthma. Thirty trials were selected involving biologics that target the IL-5 pathway, IL-13, the common IL-4 and IL-13 receptor, IL-9, IL-2 and TSLP. As no head-to-head trials were retrieved from literature, we performed an arm-based network meta-analysis to compare effects on exacerbation rate between the different treatments.Mepolizumab, reslizumab and benralizumab significantly reduced the risk of exacerbations compared to placebo (by 47-52%, 50-60%, and 28-51% respectively). Reslizumab and benralizumab also improved lung function. Dupilumab and tezepelumab improved lung function in frequent exacerbators. Lebrikizumab had no significant effect on the number of exacerbations, symptom control or health-related quality of life. Tralokinumab improved lung function compared to placebo. Network meta-analysis of all treatment and placebo arms, showed no superiority of one biolo...Continue Reading

References

May 31, 2003·BMJ : British Medical Journal·Joel LexchinOtavio Clark
Aug 29, 2006·Lancet·Sally E Wenzel
Sep 18, 2007·American Journal of Respiratory and Critical Care Medicine·Patrick Flood-PageUNKNOWN International Mepolizumab Study Group
Sep 13, 2008·American Journal of Respiratory and Critical Care Medicine·William W BusseUNKNOWN Daclizumab Asthma Study Group
Feb 25, 2009·Thorax·C K W LaiUNKNOWN International Study of Asthma and Allergies in Childhood Phase Three Study Group
Mar 7, 2009·The New England Journal of Medicine·Pranabashis HaldarIan D Pavord
Mar 7, 2009·The New England Journal of Medicine·Parameswaran NairPaul M O'Byrne
Jun 2, 2009·American Journal of Respiratory and Critical Care Medicine·Prescott G WoodruffJohn V Fahy
Jul 28, 2009·Journal of Clinical Epidemiology·David MoherUNKNOWN PRISMA Group
Nov 7, 2009·American Journal of Respiratory and Critical Care Medicine·Wendy C MooreUNKNOWN National Heart, Lung, and Blood Institute's Severe Asthma Research Program
Dec 10, 2009·Thorax·Douglas C CowanD Robin Taylor
Mar 26, 2010·Nature Reviews. Immunology·William E Paul, Jinfang Zhu
Aug 5, 2011·The New England Journal of Medicine·Jonathan CorrenJohn G Matthews
Aug 20, 2011·American Journal of Respiratory and Critical Care Medicine·Mario CastroUNKNOWN Res-5-0010 Study Group
Mar 21, 2012·BMC Public Health·Teresa ToLouis-Philippe Boulet
Apr 28, 2012·American Journal of Respiratory Cell and Molecular Biology·Tania MaesGuy G Brusselle
Jun 30, 2012·The European Respiratory Journal·Edward PiperNestor A Molfino
May 21, 2013·Nature Immunology·Paula Licona-LimónRichard A Flavell
May 22, 2013·The New England Journal of Medicine·Sally WenzelGianluca Pirozzi
Jun 4, 2013·The Journal of Allergy and Clinical Immunology·Michael NoonanJohn G Matthews
Jun 14, 2013·The Journal of Allergy and Clinical Immunology·Sejal SaglaniClare M Lloyd
Aug 8, 2013·Nature Medicine·Guy G BrusselleKen R Bracke
Nov 30, 2013·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H NeighbourP Nair
Mar 4, 2014·The Journal of Allergy and Clinical Immunology·Erika H De BoeverSally E Wenzel
Sep 10, 2014·The New England Journal of Medicine·Hector G OrtegaUNKNOWN MENSA Investigators
Sep 10, 2014·The New England Journal of Medicine·Elisabeth H BelUNKNOWN SIRIUS Investigators
Dec 3, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Robert S ZeigerTrung N Tran
Dec 3, 2014·The Journal of Allergy and Clinical Immunology·Pieter-Paul W HekkingElisabeth H Bel
Dec 3, 2014·The American Journal of Emergency Medicine·Richard M NowakNestor A Molfino
Dec 20, 2014·Annals of the American Thoracic Society·Andrew N J McKenzie
Dec 24, 2014·Nature Reviews. Immunology·John V Fahy
Oct 17, 2015·Nature Reviews. Drug Discovery·Namita A GandhiGeorge D Yancopoulos
Jan 16, 2016·Therapeutic Advances in Chronic Disease·Leena George, Christopher E Brightling
Apr 21, 2016·International Archives of Allergy and Immunology·Hae-Sim ParkUNKNOWN Asian Benralizumab Study Group

❮ Previous
Next ❯

Citations

Nov 16, 2019·Drugs·Emma D Deeks
Jan 10, 2020·Expert Opinion on Biological Therapy·Angela Moran, Ian D Pavord
Mar 7, 2020·Expert Review of Respiratory Medicine·Breda Cushen, Andrew Menzies-Gow
Apr 11, 2020·BMJ Open Respiratory Research·J Christian VirchowStephanie Korn
Jul 21, 2020·Expert Opinion on Pharmacotherapy·Timothy E AlbertsonSusan Murin
Feb 13, 2020·Pulmonary Therapy·Paola RoglianiMario Cazzola
Sep 25, 2019·Expert Review of Clinical Immunology·Marco CaminatiLanny J Rosenwasser
Jan 21, 2020·Expert Opinion on Pharmacotherapy·Timothy E AlbertsonSusan Murin
Feb 23, 2020·Drugs·Maria Gabriella MateraMario Cazzola
Jun 18, 2020·Current Allergy and Asthma Reports·Anne E ReihmanSunita Sharma
Jul 18, 2020·Journal of Clinical Medicine·Andrea Elio SprioFabio Luigi Massimo Ricciardolo
Feb 10, 2021·Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale·Francesco BandiPaolo Castelnuovo
Nov 3, 2020·Clinical and Translational Allergy·Anu Laulajainen-HongistoSanna Toppila-Salmi
Feb 4, 2021·ERJ Open Research·Gabriel GarcíaMario Rodriguez
Mar 4, 2021·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Ana Isabel Enríquez-RodríguezPere Casan Clara
Dec 10, 2020·Clinical and Translational Allergy·Anu Laulajainen-HongistoSanna Toppila-Salmi
Mar 10, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Amber N PepperThomas B Casale
Mar 10, 2020·Endocrine, Metabolic & Immune Disorders Drug Targets·Thea MagroneEmilio Jirillo
Mar 20, 2021·The Nurse Practitioner·Lynda Jarrell
Apr 1, 2020·Trends in Immunology·Sophie Guia, Emilie Narni-Mancinelli
May 1, 2021·International Journal of Molecular Sciences·Corrado PelaiaAlessandro Vatrella
Oct 24, 2020·Archivos de bronconeumología·Marina Blanco-AparicioFrancisco-Javier González-Barcala
Jun 6, 2021·Archivos de bronconeumología·Marina Blanco-AparicioFrancisco-Javier González-Barcala
Jul 27, 2021·Frontiers in Immunology·Despina MichailidouGrant C Hughes
Oct 5, 2021·Experimental and Therapeutic Medicine·Ariadna Petronela FildanDoina Tofolean
Jul 17, 2021·The European Respiratory Journal·Jonathan CorrenMichel Djandji
May 15, 2021·Minerva medica·Ahmed Edris, Lies Lahousse
Nov 12, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Roland BuhlMonica Kraft

❮ Previous
Next ❯

Software Mentioned

GINA
R
pcnetmeta
Cochrane
LAVOLTA
STRATOS

Related Concepts

Related Feeds

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.